Efficient replication systems for hepatitis C virus using a new human hepatoma cell line (Q39805946)

14 September 2017

Efficient replication systems for hepatitis C virus using a new human hepatoma cell line (English)

1 reference

14 September 2017

0 references

1 reference

hepatocellular carcinoma

1 reference

Nobuyuki Kato

1

1 reference

14 September 2017

Kyoko Mori

2

1 reference

14 September 2017

Ken-ichi Abe

3

1 reference

14 September 2017

Hiromichi Dansako

4

1 reference

14 September 2017

Misao Kuroki

5

1 reference

14 September 2017

Yasuo Ariumi

6

1 reference

14 September 2017

Takaji Wakita

7

1 reference

14 September 2017

Masanori Ikeda

8

1 reference

14 September 2017

29 August 2009

1 reference

14 September 2017

1 reference

14 September 2017

146

1 reference

14 September 2017

1-2

1 reference

14 September 2017

41-50

1 reference

Cell culture-adaptive NS3 mutations required for the robust replication of genome-length hepatitis C virus RNA.

14 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Hepatitis C virus subgenomic replicons in the human embryonic kidney 293 cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

The DNA damage sensors ataxia-telangiectasia mutated kinase and checkpoint kinase 2 are required for hepatitis C virus RNA replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Hepatitis C virus molecular clones and their replication capacity in vivo and in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Hepatitis C virus cell entry: role of lipoproteins and cellular receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Interferon-based therapy of hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Differential activation of interferon-inducible genes by hepatitis C virus core protein mediated by the interferon stimulated response element.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Genotype 2a hepatitis C virus subgenomic replicon can replicate in HepG2 and IMY-N9 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Different anti-HCV profiles of statins and their potential for combination therapy with interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Modulation of host metabolism as a target of new antivirals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Human hepatocyte clonal cell lines that support persistent replication of hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Susceptibility of human T-lymphotropic virus type I infected cell line MT-2 to hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Establishment of a hepatitis C virus subgenomic replicon derived from human hepatocytes infected in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Subgenomic replicon derived from a cell line infected with the hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Arsenic Trioxide Inhibits Hepatitis C Virus RNA Replication through Modulation of the Glutathione Redox System and Oxidative Stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Complete replication of hepatitis C virus in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Unravelling hepatitis C virus replication from genome to function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Hepatitis C virus core protein associates with detergent-resistant membranes distinct from classical plasma membrane rafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

The lipid droplet is an important organelle for hepatitis C virus production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

New efficient replication system with hepatitis C virus genome derived from a patient with acute hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Evaluation systems for anti-HCV drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Virological characterization of the hepatitis C virus JFH-1 strain in lymphocytic cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Replicons from genotype 1b HCV-positive sera exhibit diverse sensitivities to anti-HCV reagents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Persistent and transient replication of full-length hepatitis C virus genomes in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Hepatitis C virus infection is associated with the development of hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Robust hepatitis C virus infection in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

Replication of Hepatitis C Virus Subgenomes in Nonhepatic Epithelial and Mouse Hepatoma Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.08.006

10.1016/J.VIRUSRES.2009.08.006

7 January 2021

Identifiers

DOI

1 reference

14 September 2017

1 reference